These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27733043)

  • 1. Cell-Based High-Throughput Screening Assay Identifies 2',2'-Difluoro-2'-deoxycytidine Gemcitabine as a Potential Antipoliovirus Agent.
    Zhang Z; Yang E; Hu C; Cheng H; Chen CY; Huang D; Wang R; Zhao Y; Rong L; Vignuzzi M; Shen H; Shen L; Chen ZW
    ACS Infect Dis; 2017 Jan; 3(1):45-53. PubMed ID: 27733043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case for developing antiviral drugs against polio.
    Collett MS; Neyts J; Modlin JF
    Antiviral Res; 2008 Sep; 79(3):179-87. PubMed ID: 18513807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Anti-Poliovirus Compounds Isolated from Edible Plants.
    Arita M; Fuchino H
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs.
    Duintjer Tebbens RJ; Pallansch MA; Thompson KM
    BMC Infect Dis; 2015 Sep; 15():379. PubMed ID: 26382043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.
    Friedrich F
    Acta Virol; 2000 Apr; 44(2):109-17. PubMed ID: 10989702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Antiviral Activity of Gemcitabine with 2'-Fluoro-2'-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2.
    Jang Y; Shin JS; Lee MK; Jung E; An T; Kim UI; Kim K; Kim M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-555 has potent antiviral properties against poliovirus.
    Shim BS; Wu W; Kyriakis CS; Bakre A; Jorquera PA; Perwitasari O; Tripp RA
    J Gen Virol; 2016 Mar; 97(3):659-668. PubMed ID: 26683768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of antiviral agents in polio eradication.
    De Palma AM; Pürstinger G; Wimmer E; Patick AK; Andries K; Rombaut B; De Clercq E; Neyts J
    Emerg Infect Dis; 2008 Apr; 14(4):545-51. PubMed ID: 18394270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses.
    Kang H; Kim C; Kim DE; Song JH; Choi M; Choi K; Kang M; Lee K; Kim HS; Shin JS; Kim J; Han SB; Lee MY; Lee SU; Lee CK; Kim M; Ko HJ; van Kuppeveld FJ; Cho S
    Antiviral Res; 2015 Dec; 124():1-10. PubMed ID: 26526589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Analysis of Antiviral Compounds Against Poliovirus.
    Leyssen P; Franco D; Tijsma A; Lacroix C; De Palma A; Neyts J
    Methods Mol Biol; 2016; 1387():325-38. PubMed ID: 26983743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the dynamics of oral poliovirus vaccine cessation.
    Thompson KM; Duintjer Tebbens RJ
    J Infect Dis; 2014 Nov; 210 Suppl 1():S475-84. PubMed ID: 25316870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of poliovirus replication by prostaglandins A and J in human cells.
    Conti C; Mastromarino P; Tomao P; De Marco A; Pica F; Santoro MG
    Antimicrob Agents Chemother; 1996 Feb; 40(2):367-72. PubMed ID: 8834882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfated polysaccharide of Caesalpinia ferrea inhibits herpes simplex virus and poliovirus.
    Lopes N; Faccin-Galhardi LC; Espada SF; Pacheco AC; Ricardo NM; Linhares RE; Nozawa C
    Int J Biol Macromol; 2013 Sep; 60():93-9. PubMed ID: 23707733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New small-molecule inhibitors effectively blocking picornavirus replication.
    Ford Siltz LA; Viktorova EG; Zhang B; Kouiavskaia D; Dragunsky E; Chumakov K; Isaacs L; Belov GA
    J Virol; 2014 Oct; 88(19):11091-107. PubMed ID: 25008939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2.
    Cha HM; Kim UI; Ahn SB; Lee MK; Lee H; Bang H; Jang Y; Kim SS; Bae MA; Kim K; Kim M
    ACS Infect Dis; 2023 Apr; 9(4):1033-1045. PubMed ID: 36912867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating vaccine-derived polioviruses: current state of knowledge.
    Kew OM; Wright PF; Agol VI; Delpeyroux F; Shimizu H; Nathanson N; Pallansch MA
    Bull World Health Organ; 2004 Jan; 82(1):16-23. PubMed ID: 15106296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ
    Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015.
    Diop OM; Burns CC; Sutter RW; Wassilak SG; Kew OM;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):640-6. PubMed ID: 26086635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid identification of inhibitors that interfere with poliovirus replication using a cell-based assay.
    Hwang YC; Chu JJ; Yang PL; Chen W; Yates MV
    Antiviral Res; 2008 Mar; 77(3):232-6. PubMed ID: 18243348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.